Kennedy Capital Management LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
642
Total Value
4186180323
Accession Number
0000884589-25-000006
Form Type
13F-HR
Manager Name
Kennedy Capital Management LLC
Data Enrichment
97% identified
621 identified21 unidentified

Holdings

642 positions
Manager:
Search and click to pin securities to the top
Page 33 of 33
Cullinan Therapeutics, Inc.
Shares:
11643(-89.5%)
Value:
$88.1M(-93.5%)
Design Therapeutics, Inc.
Shares:
14383(+0.8%)
Value:
$55.5M(-36.9%)